Author

C. Bernado-Morales

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

J. Arribas· 2 shared A. Garcia de Herreros· 1 shared A. Gonzalez-Perez· 1 shared A. Iturbide· 1 shared A. Molina-Crespo· 1 shared A. Rojo-Sebastian· 1 shared C. Gonzalo-Consuegra· 1 shared C. Ramos-Nebot· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Arribas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gasdermin B over-expression arbitrates HER2-targeted therapy resistance by inducing protective autophagy

M. Gamez-Chiachio, A. Molina-Crespo, C. Ramos-Nebot, J. Martinez-Val, L. Martinez, K. Gassner, F. J. Llobet, C. Gonzalo-Consuegra, M. Cordani, C. Bernado-Morales, E. Diaz, A. Rojo-Sebastian, J. C. Trivino, L. Sanchez, R. Rodriguez-Barrueco, , G. Moreno-Bueno

This study identifies GSDMB over-expression as a driver of HER2-targeted therapy resistance through autophagy induction and shows that combining lapatinib with chloroquine enhances therapeutic efficacy in GSDMB-positive tumors.

Journal of Experimental & Clinical Cancer Research · Sep 26, 2022Peer-reviewedCancer Biology

Reduction of LOXL2-mediated H3K4 oxidation increases chromatin accessibility and promotes chemosensitivity of triple-negative breast cancer cells

J.P. Cebrià-Costa, L. Pascual-Reguant, A. Gonzalez-Perez, G. Serra-Bardenys, J. Querol, M. Cosín, G. Verde, R.A. Cigliano, W. Sanseverino, S. Segura-Bayona, A. Iturbide, D. Andreu, P. Nuciforo, C. Bernado-Morales, V. Rodilla, , S. Peiró

This study shows that reducing LOXL2-mediated H3K4 oxidation decreases chromatin compaction and increases chemosensitivity in triple-negative breast cancer cells.

bioRxiv · Sep 13, 2018 · PreprintCancer Biology